AKT1 and neoplasm: Consistent with the interplay between PIM kinase- and PI3K/AKT/mTORC1-mediated signaling pathways, INCB053914 enhanced the inhibitory effects of INCB050465, a highly selective PI3Kδ inhibitor, on tumor growth in a xenograft model of DLBCL.